Hadas Nicole R.
CIK 0001602396 Name as filed on the most recent filing
Filed as Hadas Nicole R. (25)
32 transaction lines · from 25 filings · filed 2014-03-27 to 2024-05-14 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.
A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.
Issuers this insider has filed against
Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.
No issuer is recorded
The catalog holds no filing linking this CIK to an issuer.
Transactions
Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.
32 transactions · Newest transaction date first, id breaking the tie.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.
| Direction | Date | Issuer | Code | Shares | Price | Value USD | Filing |
|---|---|---|---|---|---|---|---|
| 2024-05-13 |
Akebia Therapeutics, Inc. AKBA |
S, Open-market sale | 12,016 disposed | 1.26 | 15,140.16 | Form 4, filing 0001562180-24-004026 | |
| 2024-02-29 |
Akebia Therapeutics, Inc. AKBA |
S, Open-market sale | 5,974 disposed | 1.58 | 9,438.92 | Form 4, filing 0001562180-24-002022 | |
| 2024-02-27 |
Akebia Therapeutics, Inc. AKBA |
S, Open-market sale | 7,411 disposed | 1.52 | 11,264.72 | Form 4, filing 0001562180-24-001995 | |
| 2023-05-25 |
Akebia Therapeutics, Inc. AKBA |
S, Open-market sale | 63,186 disposed | 1.22 | 77,270.16 | Form 4, filing 0001562180-23-004504 | |
| 2023-03-01 |
Akebia Therapeutics, Inc. AKBA |
S, Open-market sale | 6,613 disposed | 0.88 | 5,802.91 | Form 4, filing 0001562180-23-002200 | |
| 2023-03-01 |
Akebia Therapeutics, Inc. AKBA |
S, Open-market sale | 5,333 disposed | 0.88 | 4,679.71 | Form 4, filing 0001562180-23-002200 | |
| 2023-03-01 |
Akebia Therapeutics, Inc. AKBA |
S, Open-market sale | 1,088 disposed | 0.88 | 954.72 | Form 4, filing 0001562180-23-002200 | |
| 2023-02-27 |
Akebia Therapeutics, Inc. AKBA |
S, Open-market sale | 6,677 disposed | 0.81 | 5,429.74 | Form 4, filing 0001562180-23-002037 | |
| 2022-03-01 |
Akebia Therapeutics, Inc. AKBA |
S, Open-market sale | 6,873 disposed | 2.17 | 14,919.22 | Form 4, filing 0001562180-22-002161 | |
| 2022-03-01 |
Akebia Therapeutics, Inc. AKBA |
S, Open-market sale | 6,556 disposed | 2.17 | 14,231.11 | Form 4, filing 0001562180-22-002161 | |
| 2022-03-01 |
Akebia Therapeutics, Inc. AKBA |
S, Open-market sale | 1,078 disposed | 2.17 | 2,340.01 | Form 4, filing 0001562180-22-002161 | |
| 2022-02-28 |
Akebia Therapeutics, Inc. AKBA |
S, Open-market sale | 6,555 disposed | 2.15 | 14,124.71 | Form 4, filing 0001562180-22-002161 | |
| 2021-04-01 |
Akebia Therapeutics, Inc. AKBA |
S, Open-market sale | 1,060 disposed | 3.40 | 3,604.00 | Form 4, filing 0001562180-21-002542 | |
| 2021-03-01 |
Akebia Therapeutics, Inc. AKBA |
S, Open-market sale | 7,976 disposed | 3.40 | 27,087.29 | Form 4, filing 0001562180-21-001785 | |
| 2021-03-01 |
Akebia Therapeutics, Inc. AKBA |
S, Open-market sale | 6,309 disposed | 3.40 | 21,425.99 | Form 4, filing 0001562180-21-001785 | |
| 2020-02-28 |
Akebia Therapeutics, Inc. AKBA |
S, Open-market sale | 7,050 disposed | 8.70 | 61,335.00 | Form 4, filing 0001562180-20-001936 | |
| 2017-10-02 |
Akebia Therapeutics, Inc. AKBA |
S, Open-market sale | 6,250 disposed | 19.95 | 124,687.50 | Form 4, filing 0001562180-17-003206 | |
| 2017-10-02 |
Akebia Therapeutics, Inc. AKBA |
S, Open-market sale | 1,553 disposed | 19.64 | 30,500.92 | Form 4, filing 0001562180-17-003206 | |
| 2017-07-03 |
Akebia Therapeutics, Inc. AKBA |
S, Open-market sale | 1,554 disposed | 14.26 | 22,156.47 | Form 4, filing 0001562180-17-002434 | |
| 2017-04-03 |
Akebia Therapeutics, Inc. AKBA |
S, Open-market sale | 1,556 disposed | 9.18 | 14,280.19 | Form 4, filing 0001562180-17-001429 | |
| 2017-01-01 |
Akebia Therapeutics, Inc. AKBA |
S, Open-market sale | 1,810 disposed | 10.49 | 18,987.99 | Form 4, filing 0001562180-17-000080 | |
| 2016-10-01 |
Akebia Therapeutics, Inc. AKBA |
S, Open-market sale | 1,556 disposed | 8.95 | 13,933.67 | Form 4, filing 0001562180-16-003206 | |
| 2016-07-05 |
Akebia Therapeutics, Inc. AKBA |
S, Open-market sale | 1,557 disposed | 7.47 | 11,625.34 | Form 4, filing 0001562180-16-002777 | |
| 2016-04-04 |
Akebia Therapeutics, Inc. AKBA |
S, Open-market sale | 1,556 disposed | 9.41 | 14,641.96 | Form 4, filing 0001209191-16-112923 | |
| 2016-01-04 |
Akebia Therapeutics, Inc. AKBA |
S, Open-market sale | 1,811 disposed | 12.28 | 22,239.08 | Form 4, filing 0001209191-16-089766 | |
| 2015-10-02 |
Akebia Therapeutics, Inc. AKBA |
S, Open-market sale | 1,484 disposed | 8.67 | 12,859.90 | Form 4, filing 0001209191-15-073788 | |
| 2015-07-02 |
Akebia Therapeutics, Inc. AKBA |
S, Open-market sale | 1,484 disposed | 9.54 | 14,160.48 | Form 4, filing 0001209191-15-059449 | |
| 2015-04-02 |
Akebia Therapeutics, Inc. AKBA |
S, Open-market sale | 1,483 disposed | 9.09 | 13,477.65 | Form 4, filing 0001209191-15-058358 | |
| 2015-04-02 |
Akebia Therapeutics, Inc. AKBA |
S, Open-market sale | 1,483 disposed | 9.09 | 13,477.65 | Form 4, filing 0001209191-15-032675 | |
| 2015-01-02 |
Akebia Therapeutics, Inc. AKBA |
S, Open-market sale | 1,715 disposed | 11.46 | 19,655.10 | Form 4, filing 0001209191-15-058357 | |
| 2015-01-02 |
Akebia Therapeutics, Inc. AKBA |
S, Open-market sale | 1,715 disposed | 11.46 | 19,655.10 | Form 4, filing 0001209191-15-001003 | |
| 2014-03-25 |
Akebia Therapeutics, Inc. AKBA |
P, Open-market purchase | 3,500 acquired | 17.00 | 59,500.00 | Form 4, filing 0001209191-14-023438 |
This column is intentionally blank
No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.
- S, Open-market sale
- Open-market sale
- P, Open-market purchase
- Open-market purchase
Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.
What this insider's stored lines contain
Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.
- Open-market purchase 1
- Open-market sale 31
- Option exercise 0
- Grant or award 0
- Tax withholding 0
- Disposition to the issuer 0
- In-the-money option exercise 0
How to cite this page
ebomi catalog. Hadas Nicole R., insider transactions. Retrieved 2026-08-21 from https://ebomi.com/insider/0001602396
Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6